Analysts: GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)
GLAX.NS on National Stock Exchange of India
2,305.00INR
1:31am EDT
2,305.00INR
1:31am EDT
Price Change (% chg)
Rs-12.45 (-0.54%)
Rs-12.45 (-0.54%)
Prev Close
Rs2,398.05
Rs2,398.05
Open
Rs2,301.00
Rs2,301.00
Day's High
Rs2,336.65
Rs2,336.65
Day's Low
Rs2,301.00
Rs2,301.00
Volume
2,376
2,376
Avg. Vol
23,618
23,618
52-wk High
Rs2,522.00
Rs2,522.00
52-wk Low
Rs1,801.20
Rs1,801.20
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | -- | December | 20 May 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 6 | 7 | 7 | 7 |
| (2) OUTPERFORM | 1 | 2 | 2 | 1 |
| (3) HOLD | 5 | 4 | 4 | 5 |
| (4) UNDERPERFORM | 9 | 8 | 8 | 7 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.91 | 2.73 | 2.73 | 2.71 |
Consensus Estimates Analysis
Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 1 | 6,650.00 | 6,650.00 | 6,650.00 | -- |
| Year Ending Dec-13 | 15 | 29,232.60 | 30,140.00 | 27,861.00 | 30,277.50 |
| Year Ending Dec-14 | 14 | 32,897.00 | 34,583.00 | 30,251.10 | 33,679.50 |
| Earnings (per share) | |||||
| Year Ending Dec-13 | 17 | 87.54 | 102.90 | 76.59 | 93.26 |
| Year Ending Dec-14 | 14 | 96.04 | 107.10 | 81.55 | 104.48 |
| LT Growth Rate (%) | 2 | 13.00 | 15.00 | 11.00 | 15.19 |
Historical Surprises
Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Sep-10 | 5,833.20 | 5,819.90 | 13.30 | 0.23 |
| Quarter Ending Jun-10 | 5,212.33 | 4,979.30 | 233.03 | 4.47 |
| Quarter Ending Mar-10 | 5,193.00 | 5,411.00 | 218.00 | 4.20 |
| Quarter Ending Dec-09 | 4,127.20 | 4,444.00 | 316.80 | 7.68 |
| Quarter Ending Sep-09 | 5,023.25 | 5,118.10 | 94.85 | 1.89 |
| Earnings (per share) | ||||
| Quarter Ending Sep-10 | 18.70 | 18.70 | 0.00 | 0.00 |
| Quarter Ending Jun-10 | 17.80 | 16.40 | 1.40 | 7.87 |
| Quarter Ending Sep-09 | 15.60 | 16.70 | 1.10 | 7.05 |
| Quarter Ending Jun-09 | 14.30 | 15.50 | 1.20 | 8.39 |
| Quarter Ending Mar-09 | 15.00 | 14.80 | 0.20 | 1.33 |
Consensus Estimates Trend
Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-13 | 6,650.00 | 6,650.00 | -- | -- | -- |
| Year Ending Dec-13 | 29,232.60 | 29,314.10 | 29,677.50 | 29,708.60 | 30,277.50 |
| Year Ending Dec-14 | 32,897.00 | 32,996.10 | 33,189.10 | 33,482.90 | 33,679.50 |
| Earnings (per share) | |||||
| Quarter Ending Dec-13 | 87.54 | 87.88 | 89.83 | 89.45 | 93.26 |
| Quarter Ending Dec-14 | 96.04 | 96.45 | 97.87 | 99.50 | 104.48 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-13 | 0 | 0 | -- | -- |
| Year Ending Dec-13 | 0 | 1 | 1 | 7 |
| Year Ending Dec-14 | 0 | 1 | 2 | 4 |
| Earnings | ||||
| Year Ending Dec-13 | 0 | 1 | 1 | 7 |
| Year Ending Dec-14 | 0 | 1 | 1 | 5 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: News Bites Pty Limited
|
$5.00
|
|
Provider: News Bites Pty Limited
|
$5.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates